Funding Opportunity: Increasing Uptake of Long-Acting Injectable Antiretrovirals Among People with HIV (HRSA-22-155)

This HRSA HIV/AIDS Bureau webinar reviewed the funding opportunity, Increasing Uptake of Long-Acting Injectable Antiretrovirals Among People with HIV (HRSA-22-155). "The purpose of this program is to develop, implement, and evaluate protocols for successful use of long-acting injectable (LAI) antiretroviral (ARV) medication within clinical practice."